WE evaluated the effects of sustained perinatal inhibition of NO synthase (NOS) on h_peroxia induced lung injury in newborn rats. N"-nitro-Larginine-methyl-ester (L-NAME) or untreated water was administered to pregnant rats for the final 7 days of gestation and during lactation; followed by postnatal exposure to hyperoxia (>95% 02) or room air. The survival rate of L-NAME treated pups when placed in > 95% 02 at birth was significantly lower than controls from day 4 (L-NAME, 87%; control pups, 100%, p < 0.05) to 14 (L-NAME, 0%; control pups, 53%, p < 0.05).
Introduction
Nitric oxide produced in the endothelium plays an important role in regulating vascular tone by activating soluble guanylate cyclase, which leads to smooth muscle relaxation through the synthesis of 8uanosine 3',5'-cyclic monophosphate (cGMP). The pulmonary circulation's release and response to NO, 2'3 has been shown to result in potent pulmonary vasodilator in foetal lambs. It also modulates pulmonary vascular tone during the early neonatal period. 2 
NO
has been recognized as a contributor to the decrease in pulmonary artery pressure that is crucial for a neonate's successful transition from an intrauterine to an extrauterine environment. 4 In addition to its role in the foetal and transitional neonatal circulation, it has also been shown to improve systemic arterial oxygenation in adults with lung injury. 5 Inhibition of endogenous NO formation or release decreases the production of NO by the intact lung and enhances hypoxic pulmonary vasoconstriction. 6 NO appears to play a major role in vascular tone during foetal, transitional and neonatal development.
Hyperoxia upsets the normal cellular oxidantantioxidant defence equilibrium by producin marked increases in 02 free radical production.
This process ultimately results in endothelial cell (C) to sustained chronic administration of NOS inhibitors. In the present study we explored the ability of the newborn rat to withstand a hyperoxic challenge and its associated endothelial cell injury following chronic perinatal inhibition of NOS with L-NAME, as well as foetal pulmonary artery structure and development. We hypothesized that the stress of hyperoxia to the pulmonary endothelium combined with chronic inhibition of NOS with L-NAME would have deleterious effects on the developing neonatal rat.
Materials and Methods
Animals and treatment.. Timed-pregnant rats (Holtzman, Harlan Sprague-Dawley, Indianapolis) were obtained on the 13th day of a 22-day gestation (Fig. 1) . Following a day of acclimatization the dams were randomly assigned to one of two treatment groups, either a control group or a L-NAME treatment group. In a rat the 14th day of gestation represents the beginning of the last third of pregnancy. We chose to begin NO blockade at this time since in previous work we have demonstrated consistent foetal effects with NO blockade during the last third of pregnancy. L-NAME (Sigma Chemical Co., St Pulmonary oedema was microscopically assessed in coded lung sections from evidence of interstitial or peribronchial-perivascular swelling and eosinophilic-positive staining (proteinaceous) material within the air spaces (intra-alveolar oedema). Pulmonary oedema was also assessed by comparative wet/dry lung weight ratios using non-perfused lung lobes weighed before and after drying in an 80C oven for 48 h to reach constant weight.
Foetal pulmonary artery diameter: In a subgroup of L-NAME and control animals, at gestational day 21 , dams were anaesthetized, foetuses removed by hysterotomy and rapidly frozen in The pups exposed to L-NAME had weights which remained significantly decreased after 5 days in air (-25%) or in hyperoxia (-27%) (Table 1) (p < 0.05). Lung wet weights were also significantly decreased after 5 days in hyperoxia in the L-NAME (--23%) treated offspring, but this was in proportion to the reduction in body weight, as the ratio of lung weight to body weight was unaltered (Table 1) . L-NAME treatment followed by 5 days in air or hyperoxia did not result in significant changes in the normal rate of increase of lung protein or DNA content associated with the neonatal maturation process. No differences were noted in the protein/DNA ratio with L-NAME administration although there was a tendency for this ratio to increase with hyperoxia (Table 1) .
Survival data: The offspring perinatally treated with L-NAME demonstrated a significantly decreased survival rate compared to the control offspring from the 4th day onward in hyperoxia, with the comparative 13 day survival rate being > 20 times less (2.3%) for the O2 L-NAME group vs. the O2 control group (53%) (Fig. 2) . The survival rates for the room air L-NAME and control groups were 96% and 100%, respectively. (Fig. 3) .
Lung biochemistry.. Comparative pulmonary AOE activity responses after 5 days of hyperoxia were similar between the O2-L-NAME vs. O2-control groups ( Table 2) . Following a hyperoxic challenge both L-NAME and control groups demonstrated a significant increase in CAT (99% and 104%, respectively) and GP (71% and 80%, respectively) following hyperoxic challenge (Table 2 ).
Histological studies: Qualitative examination revealed that all the O2-exposed pups (from both L-NAME and control groups) had evidence of perivascular or peribronchiolar oedema present after 5 days of hyperoxic exposure. This microscopic finding was further substantiated by the increased wet/dry lung weights of the O2-exposed offspring vs. the offspring maintained in room air from both groups. After 5 days in hyperoxia, no differences were observed in wet/ dry weights between the L-NAME (5.95 __+ 0.54) and the control (6.08 4-0.48) offspring (average air control 5.51-+_0.06). L-NAME did not appear to alter the dysmorphology associated with sustained hyperoxia (atelectasis, edema).
Discussion
Mechanisms that regulate vascular tone, growth and function in the developing pulmonary circu, lation are incompletely understood. 22 Acetylcholine, which putatively causes vascular relaxation through the release of endogenous NO, 23 is a potent pulmonary vasodilator in the foetal lamb. Following birth, it appears that endogenous NO continues to be a key nodulator of pulmonary vascular tone in the lamb. 24 Recent studies have demonstrated that the reduction of pulmonary vascular resistance after the onset of air breathing is partly caused by the release of NO from the endothelium. 25 Located between the circulation and underlying, smooth muscle, the endothelial cell plays a central role in producing changes in its physical, chemical and neurohumoral environment through the production and release of vasodilators and vasoconstrictors. At birth, the release of NO appears to be triggered by an increase in pulmonary oxygen tension, blood flow and mechanical stretch of the lung. 25 Inhibition of endogenous NO formation or release attenuates the reduction of pulmonary vascular resistance and the elevation in pulmonary artery blood flow associated with the initiation of air breathing by the lamb. 6 In rats we have previously reported a significantly higher basal NO release in newborn femoral vessels vs. adult femoral vessels, 9 suggesting that up-regulation of basal NO release is increased throughout the systemic circulation of the newborn compared to the adult.
Beyond its role in the prenatal and transitional circulation, NO However, near term (21st day of a 22 day gestation), the internal diameters of pulmonary arteries from t-NAME treated foetuses were significantly smaller than those in control foetuses (Fig. 2) 6 The summation of these pulmonary changes, compounded by hyperoxia induced endothelial cell injury, significantly alters NO production and release to the extent that mortality is significantly influenced. Further study into the ontogeny of the t-arginine:NO pathway will improve our understanding of how the transition from foetus to neonate is executed, neonatal development, and potentially target strategies for remedying damage induced to a developing neonate from a hyperoxic exposure (i.e. bronchopulmonary disease and retinopathy of prematurity).
